Main menu

Pages

Pathophysiology and causes of Jaundice

 

Pathophysiology of jaundice

 Pre-hepatic

o Increased breakdown of red cells leads to increased serum bilirubin. This unconjugated 

bilirubin isn’t water-soluble so can’t be excreted in the urine. Intestinal bacteria convert 

some of the extra bilirubin into urobilinogen, some of which is re-absorbed and IS excreted 

by the kidneys – hence urinary urobilinogen is increased.

 Hepatic

o Disorders of uptake, conjugation or secretion of bilirubin. 

o Usually divided into conjugated or unconjugated bilirubinaemia.

 The various causes of jaundice are traditionally classified into pre-hepatic, hepatic and post-hepatic 

(or cholestatic) groups according to the mechanism of the jaundice.

Pre-hepatic causes of jaundice

 Congenital red cell issues

o Cell shape

 Sickle cell disease

 Hereditary spherocytosis

 Hereditary elliptocytosis

o Enzyme

 G6PD deficiency

 Pyruvate kinase deficiency

o Haemoglobin

 Thalassemia

 Autoimmune haemolytic anaemia

 Drugs

o Penicillins

o Sulphasalazine

 Infections

o Malaria

 Mechanical

o Metallic valve prostheses

o DIC

 Transfusion reactions

 Paroxysmal nocturnal haemoglobinuria


Hepatic causes of jaundice

 Conjugated causes:

o Cirrhosis (see chronic liver disease for further causes)

o Malignancy

 Primary or metastases

o Viral hepatitis

o Drugs

 Hepatitis

 Isoniazid, rifampicin, atenolol, enalapril, verapamil, nifedipine, amiodarone, 

ketoconazole, cytotoxics, halothane

 Cholestasis


 Ciclosporin, azathioprine, chlorpromazine, cimetidine, erythromycin, nitro, 

ibuprofen, hypoglycaemics

o Enzymes

 Dubin-Johnson syndrome (DJS)

 Autosomal recessive (cMOAT gene) with excretion of conjugated bilirubin.

o Leads to pigmented liver.

 Increase in conjugated bilirubin with no other enzyme changes

 High coproporphyrin

 Rotor syndrome

 Similar to DJS

 Liver not pigmented

 Normal coproporphyrin

 Unconjugated causes of jaundice (sometimes classified as pre-hepatic causes)

o Gilbert’s syndrome

 Congenital hypo-activity of conjugation enzyme UGT-1. Benign and common (5%)

 Normal LFTs except mildly elevated bilirubin, especially in times of physiological 

stress/illness

 Normal life expectancy

o Crigler-Najar syndrome

 Autosomal recessive (type I) or dominant (type II). Severe unconjugated 

hyperbilirubinaemia.

 Congenital absence (I) or decrease (II) of glucoronyl transferase. 

 Normal liver histology.

 Treatment is liver transplant (only type II survive to adulthood)

Post-hepatic causes of jaundice

 Biliary tree obstruction

o Gallstones

o Compression e.g. pancreatitis, pancreatic tumour, lymph nodes, biliary atresia

o Cholangiocarcinoma

o Post-operative stricture 

 Primary biliary cirrhosis (see PBC section)

o M:F = 1:9

o ANA and Anti- mitochondrial antibodies

 And anti-centromere for prognosis (though more association with CREST)

 Primary sclerosing cholangitis (see PSC section)

o 80% of PSC have UC

o ANCA, anti-smooth muscle antibodies

o Association with cholangiocarcinoma


Pregnancy-associated jaundice

 Obstetric cholestasis

o 0.1-0.2% of pregnancies

o Presentation

 Itching – jaundice later

 Raised liver markers, esp ALP

o Issues

 Fetal mortality 3.5%

o Often recurs in further pregnancies

Treatment

 Ursodeoxycholic acid

HELLP (Haemolysis, Elevated Liver enzymes, Low Platelets)

o Occurs in 1-2 out of 1000 pregnancies and 10-20% of severe pre-eclampsia

o Leads to a variant of DIC

o Needs steroids and prompt delivery 

o Maternal mortality 1-24%

 Fatty liver of pregnancy

o All LFTs including synthetic function go off

 Hyperemesis gravidum

 Pre-eclampsia

o Associated with abnormal LFTs in 20% cases




Comments